DES MOINES, Iowa - Kemin Industries, Inc. presents findings from field studies which evaluated the effect of Bacillus subtilis PB6 fed to turkeys with varying degrees of Clostridial dermatitis during the 2009 American Association of Avian Pathologists/American Veterinary Medical Association meeting, July 11-14, 2009 in Seattle, Washington.
Andrew G. Yersin, Ph.D., director of research and development for Kemin Agrifoods North America, will present "Application of Bacillus subtilis PB6 in turkey field trials" during the poster session of the meeting.
The results of this study support the hypothesis that Bacillus subtilisPB6 can have a positive impact on intestinal balance in turkeys with Clostridiumdermatitis.
Bacillus subtilisPB6, a spore-forming organism, was identified in the gut of a healthy chicken by Kemin scientists. This strain was selected by Kemin due to its uniqueness, activity and positive impact on gut microflora. Bacillus subtilisPB6 is the active ingredient in CloSTAT® brand direct-fed microbial from Kemin.
Kemin® - Inspired Molecular SolutionsTM.
Founded in 1961, Kemin Industries, Inc. (www.kemin.com) provides health and nutritional solutions to the agrifoods, food ingredients, pet food, human health and pharmaceutical industries. Kemin operates in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa, and the United States.
The AgriFoods businesses of Kemin focus on Total NutritionTM to help customers achieve a highly effective, consistent system of profitable animal production. Total Nutrition focuses on understanding nutrients and nutricines and their appropriate application in animal feeds. Kemin coined the term "nutricine", a vital component of Total Nutrition, to identify ingredients that are essential in combination with good nutrition and solid animal husbandry, to maintain profitability while enhancing the health and well being of animals.
